Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Completed 41Terminated 6Recruiting 4Unknown 3Not yet recruiting 3Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 14Interventional 4

Sponsor

Cancer Type

Plasma cell 4

Conditions

Breast Neoplasms 1320Neoplasms 983Carcinoma, Non-Small-Cell Lung 858Prostatic Neoplasms 723Colorectal Neoplasms 662Lung Neoplasms 548Leukemia, Myeloid, Acute 475Neoplasm Metastasis 431Pancreatic Neoplasms 418Carcinoma, Hepatocellular 406Multiple Myeloma 397Ovarian Neoplasms 391Stomach Neoplasms 378Recurrence 365Squamous Cell Carcinoma of Head and Neck 325Melanoma 293Brain Neoplasms 287Uterine Cervical Neoplasms 283Triple Negative Breast Neoplasms 271Head and Neck Neoplasms 263Glioblastoma 263Precursor Cell Lymphoblastic Leukemia-Lymphoma 254Endometrial Neoplasms 233Lymphoma 227Esophageal Neoplasms 222Rectal Neoplasms 221Sarcoma 211Carcinoma, Renal Cell 203Colonic Neoplasms 193Lymphoma, Large B-Cell, Diffuse 191

Interventions

Curcumin 2Probiotics 1Docosahexaenoic Acids 1Diet, Plant-Based 1Diet, Mediterranean 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Interventional × Monoclonal Gammopathy of Undetermined Significance × Clear all
NCT06140524 2026-06-04

LINKER-MGUS1

Regeneron Pharmaceuticals

Phase 2 Recruiting
116 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

NCT07446777 2026-05-01

FAST-M

University of Miami

Phase NA Recruiting
120 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT05640843 2026-04-16

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
180 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

NCT06055894 2025-11-13

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
200 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡